Solana Co is a medical device firm specializing in neurotechnology dedicated to improving neurological wellness The companys strategy involves developing licensing and acquiring innovative noninvasive platform technologies These technologies are designed to enhance the brains intrinsic capacity for selfhealing and mitigate the effects of neurological diseases or trauma A prime example of their work is the development of an investigational portable neuromodulation stimulator This device uniquely delivers neurostimulation through the tongue Clinical studies have indicated that this approach significantly enhances the efficacy of physical exercises for individuals experiencing neurological symptoms stemming from conditions like disease or trauma including mildtomoderate traumatic brain injury Established on March 13 2014 Solana Co maintains its headquarters in Newtown Pennsylvania
Recent Earnings Surprises
Date
Actual EPS
Estimated EPS
Surprise
2026-05-15
$-0.29
$-0.12
141.7%
2026-03-30
$4.25
$-26.50
+-116.0%
2025-11-18
$-32.89
$-50.50
+-34.9%
2025-08-14
$-79.73
$-128.50
+-38.0%
Financial Ratios (TTM)
Gross Margin
94.17%
Operating Margin
-196.64%
Net Margin
-1,427.15%
ROA
-68.18%
Price to Book
0.67
Price to Sales
10.53
We value your privacy
We use cookies to analyze traffic and show ads. Accept all cookies, or continue with only the essential ones. Learn more